EVUSHELD 150 mg + 150 mg, solution injectable — 1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930254264 -
CIP7
3025426 -
CIS
69232595 -
Registration number
EU/1/22/1651
What the source publishes
- Holder
- ASTRAZENECA AB
- Active ingredients
- CILGAVIMAB, TIXAGÉVIMAB
- Form
- solution injectable et solution injectable
- Package
- 1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml
- Routes
- intramusculaire
- Administrative status
- cancelled
- Supply regime
- prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2022-03-25
- Prescription
- Prescription or restricted
Names this record is found by
- EVUSHELD 150 mg + 150 mg, solution injectable — 1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml
- EVUSHELD 150 mg + 150 mg, solution injectable
- CILGAVIMAB
- TIXAGÉVIMAB
Complete source data
{
"cis": "69232595",
"cip7": "3025426",
"form": "solution injectable et solution injectable",
"name": "EVUSHELD 150 mg + 150 mg, solution injectable — 1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml",
"cip13": "3400930254264",
"holder": "ASTRAZENECA AB",
"routes": [
"intramusculaire"
],
"holders": [
"ASTRAZENECA AB"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2022-03-25",
"compositions": [
{
"name": "CILGAVIMAB",
"nature": "SA",
"strength": "150 mg",
"linkageNumber": "7",
"substanceCode": "53855",
"dosageReference": "un flacon",
"pharmaceuticalElement": "solution de cilgavimab"
},
{
"name": "TIXAGÉVIMAB",
"nature": "SA",
"strength": "150 mg",
"linkageNumber": "1",
"substanceCode": "33500",
"dosageReference": "un flacon",
"pharmaceuticalElement": "solution de tixagévimab"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "EVUSHELD 150 mg + 150 mg, solution injectable",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2023-12-22",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "cancelled",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CILGAVIMAB",
"TIXAGÉVIMAB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière annuelle",
"liste I",
"renouvellement non restreint"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation abrogée",
"europeanAuthorisationNumber": "EU/1/22/1651",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930254264"